mr MARK COOKE

Advocacy for funding of Bioshield Special Reserve Fund (SRF) as authorized in the Pandemic and All-Hazards Preparedness Reauthorization Act 2013. Advocacy for funding of BARDA at HHS. Education of House and Senate staff on anthrax recombinant protective antigen vaccine and recombinant butyrlcholinesterase as an organophosphate bioscavneger for chemical nerve agent prophylaxis.

Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2013 (PAHPRA) in U.S. House and Senate. Encourage funding in FY-2014 Labor-HHS Appropriations Bill BARDA and fully funding the BioShield Special Reserve Fund (SRF) as authorized in PAHPRA. Meetings and advocacy for HHS/BARDA funding with Senate HELP Committee, Senate labor-HHS Approps and House Appropriations Committee.

Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2012 (PAHPRA) in U.S. House (HR 2405) and U.S. Senate (S.1855). Encourage continued funding for the Biodefense Advanced Research and Development Authority (BARDA) at HHS with the House Labor-HHS Appropriations Subcommittee and Senate HELP and Labor-HHS Appropriations Committee. Continued education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.

Advocacy for Reauthorization of Pandemic All-Hazards Preparedness Act (PAHPA) in House (HR 2405) and Senate (S.1855). Advocacy for House and Senate Labor-HHS Appropriations funding allocation in FY-2013 and FY-2014 for the Biodefense Advanced Research and Development Authority (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.

Advocacy for Reauthorization of Pandemic and All Hazards Preparedness Act (PAHPA) in both House (HR 2405) and Senaete (S.1855). Advocay for funding in House and Senate Labor-HHS Appropriations bills for the Biodefense Advanced Research and Development Agency (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA)anthrax vaccine.

Advocacy in House and Senate for Bills to Reauthorize the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). Advocacy in Congress for HHS/BARDA funding in FY-2013 budget (Senate Labor-HHS Appropriations and House Labor-H Appropriations. Education for Members of Congress and Staff on biodefense medical countermeasures, especially anthrax recombinant vaccine.

House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.

Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization in House and Senate. FY-2012 Funding for Biomedical Advanced Research and Development Authority (BARDA) at HHS (Labor-HHS in Senate and House Appropriations). Education of Members of Congress and Staff on bioterroism threat.

Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) in the House (H.R. 2405) and the Seante (S. 1855). Education and awareness of the need for medical countermeasures (MCM's) for chemcial and biological threats. Need for second generation recombinant anthrax vaccine (rPA).

House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin

Pandemic and All-Hazards Preparedness Act (PAHPA) Reautorization in House and Senate. FY-2012 Funding for Biomedical Research and Development Authority (BARDA) at HHS. (Labor-HHS in Senate and and House Appropriations). Eductaion of Members of Congress and Staff on bioterrorism threat.

Pandemic All-Hazards Preparedness Act (PAHPA) Reauthorization; Biodefense Advanced Research and Development Authority (BARDA) Funding in 2011 Continuing Resolution and President's FY-2012 Budget; Medical Countermeasures for Bacillus Anthracis including recombinant protective Antigen (rPA) vaccine and antitoxins.

Pandemic All-Hazards preparedness Act (PAHPA) Reauthorization; Biomedical Advanced Research and Development Authority (BARDA) funding at HHS for 2011; Education on threat of bioterrorism and urgency for development of Medical Countermeasures (MCM's) including new, modern recombinant Protective Antigen anthrax vaccine (rPA), anthrax antitoxin monoclonal antibody therapeutic and chemical nerve agent bioscavenger.

BARDA (Biodefense Advanced Research and Development AUthority) funding in FY-2011 Senate Labor-HHS Appropriations Bill; Education on bioterrorism threat to the nation and advocacy for procurement of late-stage vaccine and therapeutic technology; Retention of Project BioShield Special Reserve (SRF) Funds and their replenishment;DoD CBMS funding for organophosphate bioscavenger for chemcial nerve agents.

BARDA (Biodefense Advanced Research and Development Authority) funding in FY-2011 Labor-HHS Appropriations Bill; Biodefense threat to the nation and education on vaccines and therapeutics; Project BioShield Special Reserve Fund (SRF) replenishment and sustainability; Dept of Defense Chem-Bio Medical Systems (CBMS) funding for organophosphate bioscavenger against chemical nerve agents.

HHS - Biodefense Research and Development Authority FY-2011 funding. Anthrax vaccine (rPA) development contract modification. Chemical nerve agent bioscavenger FY-2011Defense Appropriations funding. Senate HELP Committee, biodefense awareness of threat and funding for medical countermeasures. Senate Labor-HHS appropriations. House Labor-HHS Aproppriations. House and Senate Homeland Security Committees (biodefense education and funding). E&C Health Subcomm.

Senate, Labor HHS Appropriations; Senate HELP Committee; Senate Defense Appropriations; Senate Homeland Security & Government Affairs Committee; House Labor HHS Appropriations Subcommittee; House Homeland Security Committee. BARDA/HHS funding. BARDA funding/contract modification for anthrax rPA vaccine. Defense appropriations for funding of recombinant chemical nerve agent bioscavenger.

HR-3293 Department of Labor, Health and Human Services and Education Appropriations Act for 2010: All provisions relating to development, acquisition and stockpilingof biodefense vaccines and therapeutics; Appropriations advocacy; BARDA funding. HHS procurement contract of recombinant anthrax vaccines. S.1649 - WMD Prevention and Preparedness Act of 2009 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines and therapeutics. Support and Funding for the Biomedical Advanced Research and Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines and therapeutics. Department of Defense Chemical- Biological Medical Systems (CBMS) funding for organophosphate bioscavenger advanced research and development.

BARDA (Biomedical Advanced Research and Development Authority) funding in FY 2010 Labor HHS Appropriations Bill. Support for Health & Human Services (HHS) anthrax vaccine and antitoxin Request For Proposal (RFP) and Procurement contracts. Increased funding for Project Bioshield within Pandemic and All Hazards Preparedness Act for Medical Countermeasure acquisition. Department of Defense Chemical-Biological Medical Systems (CBMS) funding for organophosphate bioscavenger funding.

BARDA (Biodefense Advanced Research and Development Authority) Funding in FY2009 Supplemental Appropriations Act (PL 111-32) as well as in American Recovery and Reinvestment Act of 2009 (PL 111-5) to fund vaccines and therapeutics against CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threats to the U.S. Funding for BARDA/HHS in the Presidents FY2010 Budget.

Biodefense Advanced Research and Development Authority (BARDA-HHS) funding in Supplemental and FY-2010 Budget. Vaccines and Therapeutics for CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threat to the U.S. FY-2010 Defense Appropriations requests for Chemical Nerve Agent Antidote and Anthrax Therapeutic Monoclonal Antibody

Biodefense advanced research and development funding for BARDA/HHS. Economic Stimulus Funding for HHS, BARDA and NIH to support advanced R&D for biodefense vaccines and therapeutics.

Biodefense advanced research and development funding (BARDA). Economic Stimulus Funding for HHS (BARDA, NIH) Awaerness of biological and chemical terrorism threats to military and civialian populations.

Biodefense advanced research and development funding (BARDA). Economic Stimulus Funding for HHS (BARDA, NIH) Awaerness of biological and chemical terrorism threats to military and civialian populations.

Health & Human Services (HHS) anthrax vaccine and antitoxin. Avanced research and development. BARDA funding. Project Bioshield. Biodefense

Health & Human Services (HHS) anthrax vaccine and antitoxin. Avanced research and development. BARDA funding. Project Bioshield. Biodefense

Biodefense Advanced Research and Development funding for BARDA/HHS. Economic Stimulus/Recovery funding for HHS, BARDA and NIH to supprt advanced R&D for biodefense vaccines and therapeutics.

Health & Human Services (HHS) anthrax vaccine and antitoxin. Avanced research and development. BARDA funding. Project Bioshield. Biodefense

BIODEFENSE, PROJECT BIOSHIELD, BARDA, FOOD CONSERVATION AND ENERGY ACT

Biodefense, Project Bioshield, BARDA appropriations

Biodefense, Project BioShield, BARDA

Biodefense, Project BioShield, advanced development funding

S. 3678 Pandemic and All Hazards Preparedness Act now law - authorized advanced development funding for biodfense and infectious disease technologies. Plus-Up funding for our lead product Valortim.

S, 3678 - the Pandemic and All Hazards Preparedness Act. This bill now law authroized a new advancded development authority for biodfense and infectious disease technologies.